Arcutis Biotherapeutics, Inc. (ARQT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 2.24M | 26.18M | -1.75M | 324K | -30.38M | -748K | -34.69M | -45.12M | -31.6M | -56.24M | -43.98M | -66.48M |
| Operating CF Margin % | 2.12% | 20.22% | -1.77% | 0.4% | -46.14% | -1.05% | -77.51% | -146.21% | -63.76% | -415.82% | -115.42% | -1281.02% |
| Operating CF Growth % | 107.37% | 3600.67% | 94.94% | 100.72% | 3.87% | 98.67% | 21.14% | 32.14% | 60.67% | 20.86% | 35.03% | -7.27% |
| Net Income | -11.29M | 17.39M | 7.41M | -15.89M | -25.06M | -10.79M | -41.54M | -52.33M | -35.38M | -66.28M | -44.77M | -70.99M |
| Depreciation & Amortization | 562K | 563K | 562K | 410K | 3.13M | 458K | 1.77M | 17K | 358K | 385K | 387K | 386K |
| Stock-Based Compensation | 0 | 10.06M | 10.04M | 10.49M | 9.78M | 9.39M | 9.78M | 12.52M | 10.03M | 8.76M | 10M | 10.58M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.33M | 0 | 0 |
| Other Non-Cash Items | 11.18M | 493K | 181K | 183K | -543K | 1.76M | -897K | -1.06M | -1.17M | 16.82M | -425K | -732K |
| Working Capital Changes | 1.79M | -2.33M | -19.94M | 5.13M | -17.69M | -1.57M | -3.8M | -4.27M | -5.44M | 411K | -9.18M | -5.73M |
| Change in Receivables | 1.85M | -31.11M | -8.43M | -21.27M | -12.35M | -14.13M | -16.61M | -5.18M | -11.35M | -6.39M | -2.21M | -4.44M |
| Change in Inventory | -14.58M | -5K | -5.89M | 518K | -1.95M | -265K | 611K | -633K | -113K | 779K | -3.44M | -1.92M |
| Change in Payables | 5.61M | 6.73M | -9.29M | 554K | 309K | -105K | 6.51M | -5.16M | 992K | -1.19M | -3.97M | 4.94M |
| Cash from Investing | -11.33M | -34.18M | -25.25M | 17.42M | 11.75M | 34.88M | 84.78M | -62.14M | -28.7M | -62.19M | 45.55M | 89.12M |
| Capital Expenditures | 0 | 0 | 0 | -78K | -608K | -5M | -143K | 0 | 0 | -6K | -64K | -276K |
| CapEx % of Revenue | - | - | - | 0.1% | 0.92% | 7.01% | 0.32% | - | - | 0.04% | 0.17% | 5.32% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 62.18M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -10M | 0 | 0 | 0 | 0 | 0 | -62.18M | 0 | 0 |
| Cash from Financing | 1.07M | 3.72M | 1.48M | 1.38M | 395K | -97.41M | 394K | 1.46M | 161.76M | 99.29M | 867K | 1.07M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.07M | 3.72M | 0 | 1.38M | 0 | 0 | 0 | 0 | 161.68M | 98.9M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 1.48M | 0 | 395K | -97.41M | 394K | 1.46M | 82K | 388K | 867K | 1.07M |
| Net Change in Cash | -8.14M | -4.21M | -25.62M | 19.33M | -18.23M | -63.52M | 50.58M | -105.83M | 101.39M | -19.07M | 2.36M | 23.71M |
| Free Cash Flow | 2.24M | 26.18M | -1.75M | 246K | -30.99M | -5.75M | -34.83M | -45.12M | -31.6M | -56.25M | -44.05M | -66.76M |
| FCF Margin % | 2.12% | 20.22% | -1.77% | 0.3% | -47.06% | -8.05% | -77.83% | -146.21% | -63.76% | -415.87% | -115.58% | -1286.34% |
| FCF Growth % | 107.23% | 555.55% | 94.96% | 100.55% | 1.95% | 89.78% | 20.92% | 32.42% | 60.71% | 20.98% | 51.41% | -7.57% |
| FCF per Share | 0.02 | 0.19 | -0.01 | 0.00 | -0.25 | -0.05 | -0.28 | -0.37 | -0.28 | -0.61 | -0.71 | -1.09 |
| FCF Conversion (FCF/Net Income) | -0.20x | 1.51x | -0.24x | -0.02x | 1.21x | 0.07x | 0.84x | 0.86x | 0.89x | 0.85x | 0.98x | 0.94x |
| Interest Paid | 0 | 0 | 2.62M | 0 | 2.57M | 2.96M | 6.23M | 6.51M | 6.51M | 0 | 6.55M | 6.31M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |